PsiQuantum
AllocationsX price
30.40 USD
-10.59% all time
Last match
33.00
Sep 22, 2026
Highest bid
33.00
Lowest ask
26.00
Implied market cap
$5.28B
Live supply
8.1M
Live demand
350.1K
Matches
229
All time
PsiQuantum price
$17.08
Sep 25, 2025
The AllocationsX price is a per-security model indicative price estimate. It is calculated daily using a time-decayed, volume-weighted blend of confirmed transactions and bid/ask indications on the platform, weighted to favor recent, higher-volume activity. It is not a quote and does not represent an executable price.
About PsiQuantum
PsiQuantum — Photonic quantum computing platform. PsiQuantum works with institutional and accredited investors to build category-defining products in the private markets.
- Founded
- 2020
- Employees
- 1001-5000
- Headquarters
- Boston, Massachusetts
- Website
- psiquantum.com
Market depth
LivePrice per share
For illustrative purposes only. Depth reflects the estimated cumulative dollar value of open buy indications currently posted on AllocationsX, including non-confirmed open orders.
PsiQuantum transaction data
Detailed transaction data from the past year. Each row includes price per share, transaction size, share and transfer type, and status.
| Date | Share type | Transfer type | Status | ROFR | Price per share | Size |
|---|---|---|---|---|---|---|
| Sep 22, 2026 | Common | Forward | In progress | — | $24.93 | $5M-$20M |
| Aug 14, 2026 | Preferred | Direct | Closed | Waived | $26.75 | $1M-$5M |
| Jul 30, 2026 | Options | Indirect | In progress | Waived | $28.58 | $500K-$1M |
| Jun 18, 2026 | SAFE | Forward | Cancelled | — | $30.40 | $20M-$50M |
Showing 4 of 4 transactions
Funding history
PsiQuantum has raised across 4 identified funding rounds.
| Date | Class | Total raised | Valuation | PPE | Investors |
|---|---|---|---|---|---|
| May 2026 | Series H | $5B | $61B | — | Andreessen Horowitz, Thrive Capital |
| June 2025 | Series G | $2.5B | $30.5B | — | Founders Fund |
| August 2024 | Series F | $1.5B | $14B | — | Founders Fund, Sands Capital, Baillie Gifford, Counterpoint Global |
| December 2022 | Series E | $1.5B | $8.5B | — | Valor Equity Partners, Andreessen Horowitz, General Catalyst |
Data provided for informational purposes only and should not be the basis of an investment decision. AllocationsX has not verified this data as accurate or up to date.